The report "Spinal Fusion Devices Market by Product (Thoracolumbar Fusion Devices (Anterior, Interbody Fusion), Cervical Fusion Devices (Anterior Cervical Plates, Anterior Cervical Screws, Cervical Interbody Fusion Devices, Posterior Cervical Plates, Posterior Cervical Screws, Posterior Cervical Rods)), Surgery (Open, MIS), End-User (Hospitals, Trauma Centers) – Global Forecasts to 2027", is projected to reach USD 8.9 billion by 2027 from USD 6.5 Billion in 2022, at a CAGR of 6.5% during the forecast period
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/spinal-fusion-devices-market-226892479.html
Factors such as rising incidence of spinal disorders & related accidental cases, technological advancements in the field of surgical implants & related biomaterials, availability of reimbursements for target surgical procedures in mature markets, and rising awareness about the different surgical modalities are expected to support the growth of spinal fusion devices market.
Thoracolumbar fusion devices to command the largest revenue share as of 2022
Based on product type, the spinal fusion devices market is segmented into Cervical fixation devices and Thoracolumbar fusion devices. In 2022, thoracolumbar fusion devices accounted for the largest share, mainly owing to rising cases of spinal & back pain coupled with a growing number of related surgical procedures worldwide.
North America to command the largest share of the Spinal fusion device market in 2022
Based on region, the spinal fusion devices market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account for the largest spinal fusion devices market share in 2022. The dominant position of the North American market is primarily driven by the high prevalence of spinal conditions, the rapid adoption of hybrid & 3D-printed surgical implants, and well-established players in the region.
As of 2022, major players operating in the spinal fusion devices market include Zimmer Biomet Holdings, Stryker Corporation, Exactech, Globus Medical, NuVasive, Medtronic Plc, Captiva Spine, Centinel Spine, Johnson & Johnson, Orthofix International, Seaspine, Wenzel Spine, and B Braun Melsungen, among others.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com